RS50051B - Derivati 3-azabiciklo(3.1.0) heksana kao ligandi opijatskih receptora - Google Patents

Derivati 3-azabiciklo(3.1.0) heksana kao ligandi opijatskih receptora

Info

Publication number
RS50051B
RS50051B YUP-415/01A YU41501A RS50051B RS 50051 B RS50051 B RS 50051B YU 41501 A YU41501 A YU 41501A RS 50051 B RS50051 B RS 50051B
Authority
RS
Serbia
Prior art keywords
aryl
alkyl
optionally substituted
4alkyl
4alkoxy
Prior art date
Application number
YUP-415/01A
Other languages
English (en)
Inventor
Bernard Joseph Banks
Robert James Crook
Stephen Paul Gibson
Graham Lunn
Alan John Pettman
Original Assignee
Pfizer Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828485.4A external-priority patent/GB9828485D0/en
Priority claimed from GBGB9912425.7A external-priority patent/GB9912425D0/en
Application filed by Pfizer Inc., filed Critical Pfizer Inc.,
Publication of YU41501A publication Critical patent/YU41501A/sh
Publication of RS50051B publication Critical patent/RS50051B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YUP-415/01A 1998-12-23 1999-11-19 Derivati 3-azabiciklo(3.1.0) heksana kao ligandi opijatskih receptora RS50051B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828485.4A GB9828485D0 (en) 1998-12-23 1998-12-23 Compounds useful in therapy
GBGB9912425.7A GB9912425D0 (en) 1999-05-27 1999-05-27 Compounds useful in therapy

Publications (2)

Publication Number Publication Date
YU41501A YU41501A (sh) 2004-03-12
RS50051B true RS50051B (sr) 2008-11-28

Family

ID=40257194

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-415/01A RS50051B (sr) 1998-12-23 1999-11-19 Derivati 3-azabiciklo(3.1.0) heksana kao ligandi opijatskih receptora

Country Status (10)

Country Link
KR (1) KR100504647B1 (sr)
AR (1) AR035157A1 (sr)
CO (1) CO5261495A1 (sr)
IL (1) IL142697A (sr)
MY (1) MY130771A (sr)
PA (1) PA8488001A1 (sr)
PE (1) PE20001318A1 (sr)
PT (1) PT1140828E (sr)
RS (1) RS50051B (sr)
TN (1) TNSN99235A1 (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007267183B2 (en) 2006-05-31 2011-10-20 F. Hoffmann-La Roche Ag Aryl-4-ethynyl-isoxazole derivatives

Also Published As

Publication number Publication date
YU41501A (sh) 2004-03-12
PT1140828E (pt) 2006-12-29
AR035157A1 (es) 2004-05-05
KR100504647B1 (ko) 2005-07-29
CO5261495A1 (es) 2003-03-31
IL142697A (en) 2009-05-04
PE20001318A1 (es) 2000-12-01
MY130771A (en) 2007-07-31
PA8488001A1 (es) 2002-10-28
TNSN99235A1 (fr) 2005-11-10
KR20010086462A (ko) 2001-09-12

Similar Documents

Publication Publication Date Title
HRP20010477B1 (en) 3-azabicyclo[3.1.0]hexane derivatives as opiate receptor ligands
CA2418908A1 (en) 1,4-dihydropyridines as bradykinin antagonists
CA2280753A1 (en) 1,4-substituted cyclic amine derivatives
MX9800867A (es) Halogenobencimidazoles y su empleo como microbicidas.
HUP0301330A2 (hu) 2-Aminokarbonil-9H-purin-származékok
HUP0401067A2 (hu) Defenilazetidinon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK1260512T3 (da) Hidtil ukendte, cykliske amidderivater
RS50429B (sr) Novi spirotriciklični derivati i njihova upotreba kao inhibitora fosfodiesteraze-7
HUP0401073A2 (hu) Difenilazetidinon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PT1140916E (pt) Acetais heteroarilo ciclicos
DE69810958D1 (de) Harnstoffderivate und ihre anwendung als integrin-inhibitoren
MXPA02006329A (es) 8-arilquinolinas sustituidas que son inhibidores de fosfodiesterasa-4.
CA2128205A1 (en) Methotrexate derivatives
CA2159817A1 (en) Pyrimidine Acyclonucleoside Derivatives
EA200200558A1 (ru) 2-( 1h-индол-3-ил)-2-оксоацетамиды, обладающие противоопухолевой активностью
DE69330612D1 (de) Neue pyridon carbonsäure-derivate
ATE502005T1 (de) Amphotere lipidverbindung und deren verwendung
HUP0001603A2 (hu) Cikloalkil-alkánkarbonsavamidok, előállításuk és alkalmazásuk
YU47219B (sh) Antivirusna tetrahidroimidazo (1,4) benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje
RS50051B (sr) Derivati 3-azabiciklo(3.1.0) heksana kao ligandi opijatskih receptora
YU75394A (sh) Anelirani dihidropiridini i njihova primena za pripremanje farmaceutskih preparata
KR860000286A (ko) 디히드로피리딘 유도체의 제조방법
ES2120498T3 (es) Nuevo compuesto tetraciclico.
ATE396987T1 (de) Variolinderivate und ihre verwendung als cytostatika
HUP9701316A2 (hu) Helyettesített indanilidin-acetil-guanidin-származékok, eljárás előállításukra, és ezeket tartalmazó gyógyászati készítmények és diagnosztikumok